0 results for 'GlaxoSmithKline'
Defendant Granted Disclosure of Documents Wrongly Withheld as Privileged, Work Product
Former GSK Patent Leader Moves to Troutman Pepper
Duke Fitch started at the company as a medicinal chemist and rose to vice president of U.S. pharmaceutical patents after earning his law degree.Dechert Partner Who Repped J&J, 3M and BP in High-Profile Trials Moves to Paul Weiss
Kimberly Branscome joins Paul Weiss's Los Angeles office after nearly four years at Dechert.No Jurisdiction Over Defendant; State Lacked Connections to Party
View more book results for the query "GlaxoSmithKline"
Deal Watch: Kirkland, Akin Drive Energy Deals as Big Law Leans Into Sector for M&A
Four of the five announced M&A deals of more than $1 billion in the past week involved the energy and infrastructure sectors.Pharmaceutical Legal and Regulatory Trends To Watch in 2024
This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.Shearman's Co-Managing Partner Leads Team Move to Linklaters in New York
The six-person team is departing ahead of the firm's merger with Allen & Overy, which will see A&O leaders take charge of the combined firm.Deal Watch: Big Law Dealmakers Are Evaluating These Factors to Assess 2024 Market
Frank Aquila, partner in Sullivan & Cromwell's corporate group, said the tempering of inflation and the broader economic news that ushers in could be a boon for M&A in 2024.Debra D. Pierce v. Archer Daniels Midland, Co., et al.
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now